InvestorsHub Logo
Post# of 252714
Next 10
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

Re: DewDiligence post# 45551

Sunday, 04/22/2007 4:38:07 PM

Sunday, April 22, 2007 4:38:07 PM

Post# of 252714
Thanks Dew for the distinction. Based on the press release, my understanding was that the ALNY's drug contains two separate RNAi nucleotides-one targeting VEGF and the other targeting KSP (two separate active ingredients). Consequently, I was suprised that they were not running mono trials first.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.